綠康生化(002868.SZ):擬2730萬元將武漢綠康100%股權轉讓給浦潭熱能
格隆匯6月28日丨綠康生化(002868.SZ)公佈,公司為聚焦主營業務,加強對下屬子公司的業務協同性管理,進一步優化資產和業務結構,公司擬將全資子公司武漢綠康生化科技有限公司(以下簡稱“武漢綠康”)100%股權轉讓給福建浦潭熱能有限公司(以下簡稱“浦潭熱能”),交易價格為2,730萬元。本次交易完成後,公司將不再持有武漢綠康的股權,武漢綠康將不再納入公司的合併報表範圍,本次交易不涉及對標的公司會計核算方法變更。
公司已委託銀信資產評估有限公司對擬出售的武漢綠康股東全部權益進行評估,評估值為2,729.80萬元,評估對象賬面所有者權益1,646.21萬元,股東全部權益評估增值1,083.59萬元,增值率為65.82%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.